CN Bio, a leading provider of Organ-on-a-chip (OOC) systems and solutions that accelerate drug discovery and development workflows, has introduced two
CN Bio expands access to OOC solutions for APAC customers with distributor agreement in South Korea
Partnership with SCINCO strengthens international sales and technical support channels in key region as part of ongoing global expansion CN Bio, a
Microphysiological systems for mAbs development: how do they address animal limitations?
Welcome to part two of our blog series exploring the FDA’s announcement to phase out the animal testing requirement for monoclonal antibodies (mAbs),
Why the FDA animal testing phase-out for monoclonal antibodies?
In a groundbreaking press release on April 10th, 2025, the FDA announced its decision to phase out animal testing requirements for monoclonal
CN Bio and Pharmaron establish long-term strategic partnership to develop OOC technologies on a global R&D platform
CN Bio and Pharmaron partnership to validate and promote the application of CN Bio’s PhysioMimix technology, with future opportunities for novel
FDA’s plan to phase out animal testing requirement for monoclonal antibodies and other drugs with more human-relevant methods
Implementation of this new regimen will begin immediately for investigational new drug (IND) applications, where the inclusion of NAMs data is now
The Rise of Oligonucleotide Therapeutics: Overcoming ADMET Development Challenges with Human-Centric Approaches
New modality drugs, or advanced oligonucleotide therapeutics, refer to innovative approaches that go beyond traditional small molecule approaches to
CN Bio launches PhysioMimix® DILI assay kit: Human 24
CN Bio, a leading provider of Organ-on-a-chip (OOC) Systems and solutions that accelerate drug discovery and development workflows, today announced
CN Bio signs strategic partnership with Primetech Corporation to establish distribution channel for OOC solutions in Japan
Agreement establishes direct distribution channel for customers in Japan, providing local support and expertise. Partnership solidifies CN Bio’s